- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 233/70 - Un atome d'oxygène
Détention brevets de la classe C07D 233/70
Brevets de cette classe: 129
Historique des publications depuis 10 ans
|
15
|
8
|
7
|
8
|
12
|
9
|
12
|
11
|
7
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 550 |
9 |
| Buck Institute for Research on Aging | 122 |
6 |
| Theravance, Inc. | 93 |
6 |
| The Regents of the University of California | 18943 |
5 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
5 |
| The Regents of the University of Michigan | 4409 |
3 |
| Cornell University | 3036 |
3 |
| Pliant Therapeutics, Inc. | 53 |
3 |
| Janssen Pharmaceutica N.V. | 3839 |
2 |
| Centre National de La Recherche Scientifique | 9632 |
2 |
| FUJIFILM Corporation | 27102 |
2 |
| President and Fellows of Harvard College | 5792 |
2 |
| CHDI Foundation, Inc. | 104 |
2 |
| Neuropore Therapies, Inc. | 39 |
2 |
| The Penn State Research Foundation | 1423 |
2 |
| Shikoku Chemicals Corporation | 78 |
2 |
| Universite D'orleans | 128 |
2 |
| Vanderbilt University | 1731 |
2 |
| Nantneuro, LLC | 4 |
2 |
| Migal Galilee Research Institute Ltd. | 48 |
2 |
| Autres propriétaires | 65 |